Decreased platelet function in Cavalier King Charles Spaniels with mitral valve regurgitation

Journal of Veterinary Internal Medicine

Volumn 17, Issue 5, 2003, Pages 680-686

  Tarnow, Inge ^a   Kristensen, Annemarie T ^a   Texel, Helle ^a   Olsen, Lisbeth H ^a   Pedersen, Henrik D ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Mitral valve prolapse; PFA 100; Platelet activation; Thrombocytopenia

Indexed keywords

ARTICLE; BREED; CONTROLLED STUDY; DISEASE SEVERITY; DOG; FEMALE; MALE; MEMBRANE; MITRAL VALVE PROLAPSE; MITRAL VALVE REGURGITATION; NONHUMAN; SHEAR STRESS; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA;

ANIMALS; CASE-CONTROL STUDIES; DOG DISEASES; DOGS; ECHOCARDIOGRAPHY; FEMALE; MALE; MITRAL VALVE INSUFFICIENCY; PEDIGREE; PLATELET AGGREGATION; PLATELET FUNCTION TESTS;

CANIS FAMILIARIS;

EID: 0141993041     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2003)017<0680:DPFICK>2.3.CO;2     Document Type: Article

References (50)

1. Beardow AW, Buchanan JW. Chronic mitral valve disease in Cavalier King Charles Spaniels - 95 cases (1987-1991). J Am Vet Med Assoc 1993;203:1023-1029.
2. Haggstrom J, Hansson K, Kvart C, Swenson L. Chronic valvular disease in the Cavalier King Charles Spaniel in Sweden. Vet Rec 1992; 131:549-553.
3. Pedersen HD, Kristensen BO, Lorentzen KA, et al. Mitral valve prolapse in 3-year-old healthy Cavalier King Charles Spaniels - An echocardiographic study. Can J Vet Res 1995;59:294-298.
4. Pedersen HD, Lorentzen KA, Kristensen BO. Echocardiographic mitral valve prolapse in cavalier King Charles spaniels: Epidemiology and prognostic significance for regurgitation. Vet Rec 1999;144:315-320.
5. Pedersen HD, Haggstrom J. Mitral valve prolapse in the dog: A model of mitral valve prolapse in man. Cardiovasc Res 2000;47:234-243.
6. Pedersen HD. Mitral Valve Prolapse in the Dog. Pathogenesis, Pathophysiology, Diagnosis and Comparative Aspects of Early Myxomatous Mitral Valve Disease. Copenhagen: The Royal Veterinary and Agricultural University; 2000. Thesis.
7. Brown SJ, Simpson KW, Baker S, et al. Macrothrombocytosis in Cavalier King Charles Spaniels. Vet Rec 1994;135:281-283.
8. Eksell P, Haggstrom J, Kvart C, Karlsson A. Thrombocytopenia in the Cavalier King Charles Spaniel. J Small Anim Prac 1994;35: 153-155.
9. Smedile LE, Houston DM, Taylor SM, et al. Idiopathic, asymptomatic thrombocytopenia in Cavalier King Charles spaniels: 11 cases (1983-1993). J Am Anim Hosp Assoc 1997;33:411-415.
10. Pedersen HD, Haggstrom J, Olsen LH, et al. Idiopathic asymptomatic thrombocytopenia in Cavalier King Charles Spaniels is an autosomal recessive trait. J Vet Intern Med 2002;16:169-173.
11. Callan MB, Giger U. Assessment of a point-of-care instrument for identification of primary hemostatic disorders in dogs. Am J Vet Res 2001;62:652-658.
12. Olsen LH, Kristensen AT, Haggstrom J, et al. Increased platelet aggregation response in Cavalier King Charles Spaniels with mitral valve prolapse. J Vet Intern Med 2001;15:209-216.
13. Arocha F, Diez-Ewald M, Durango AI, Sulbaran T. Platelet activity in mitral valve prolapse: A study of platelet aggregation, malondialdehyde production, and plasma beta-thromboglobulin. Am J Hematol 1985;19:21-25.
14. Fisher M, Weiner B, Ockene IS, et al. Platelet activation and mitral valve prolapse. Neurology 1983;33:384-386.
15. Steele P, Weily H, Rainwater J, Vogel R. Platelet survival time and thromboembolism in patients with mitral valve prolapse. Circulation 1979;60:43-45.
16. Buchanan JW, Beardow AW, Sammarco CD. Femoral artery occlusion in Cavalier King Charles Spaniels. J Am Vet Med Assoc 1997;211:872-874.
17. Karlstam E, Haggstrom J, Kvart C, et al. Pulmonary artery lesions in Cavalier King Charles Spaniels. Vet Rec 2000;147:166-167.
18. Francis JL. Platelet dysfunction detected at high shear in patients with heart valve disease. Platelets 2000;11:133-136.
19. Martini F, Zuppiroli A, Gori AM, et al. Platelet and blood clotting activation in patients with mitral valve prolapse. Thromb Res 1996;83:299-306.
20. Obrien JR, Etherington MD, Brant J, Watkins J. Decreased platelet function in aortic valve stenosis - High shear platelet activation then inactivation. Br Heart J 1995;74:641-644.
21. Tanaka R, Yamane Y. Platelet aggregation in dogs with mitral valve regurgitation. Am J Vet Res 2000;61:1248-1251.
22. Obrien JR. Platelet activation at high and low shear is followed by inactivation - The clinical relevance. Platelets 1995;6:242-243.
23. Slaughter TF, Sreeram G, Sharma AD, et al. Reversible shear-mediated platelet dysfunction during cardiac surgery as assessed by the PFA-100® platelet function analyzer. Blood Coagul Fibrinolysis 2001;12:85-93.
24. Shiroshita Y, Tanaka R, Shibazaki A, Yamane Y. Retrospective study of clinical complications occurring after arterial punctures in 111 dogs. Vet Rec 2000;146:16-19.
25. Kundu SK, Heilmann EJ, Sio R, et al. Description of an in vitro platelet function analyzer - PFA-100®. Sem Thromb Hemost 1995;21: 106-112.
26. Keidel A, Mischke R. Clinical evaluation of platelet function analyzer PFA-100 in dogs. Berl Munch Tierarztl Wochenschr 1998; 111:452-456.
27. Mammen EF, Comp PC, Gosselin R, et al. PFA-100 system: A new method for assessment of platelet dysfunction. Semin Thromb Hemost 1998;24:195-202.
28. Haggstrom J, Hansson K, Karlberg BE, et al. Plasma concentration of atrial-natriuretic-peptide in relation to severity of mitral regurgitation in Cavalier King Charles Spaniels. Am J Vet Res 1994;55: 698-703.
29. Pedersen HD, Olsen LH, Mow T, Christensen NJ. Neuroendocrine changes in Dachshunds with mitral valve prolapse examined under different study conditions. Res Vet Sci 1999;66:11-17.
30. Pedersen HD, Haggstrom J, Falk T, et al. Auscultation in mild mitral regurgitation in dogs: Observer variation, effects of physical maneuvers, and agreement with color Doppler echocardiography and phonocardiography. J Vet Intern Med 1999;13:56-64.
31. Cornell CC, Kittleson MD, Della Torre P, et al. Allometric scaling of M-mode variables in normal adult dogs. Proceedings of the 11th Annual Congress, European Society of Veterinary Internal Medicine, Dublin, Ireland, September 2001.
32. Favaloro EJ, Facey D, Henniker A. Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders. Am J Hematol 1999;62:165-174.
33. Kristensen AT, Texel H, Pedersen HD. Intact primary hemostatic responses in Cavalier King Charles Spaniels with macrothrombocytopenia. Proceedings of the 19th American College of Veterinary Internal Medicine Forum, Dallas, Texas, June 2002.
34. Saleh N, Hansson LO, Kohut M, et al. Platelet function and myocardial injury during percutaneous coronary intervention. J Thromb Thrombolysis 2002;13:69-73.
35. Serebruany VL, Alford AB, Meister AF, et al. Clinical utility of the platelet function analyzer (PFA-100) for the assessment of the platelet status in patients with congestive heart failure (EPCOT trial). Thromb Res 2001;101:427-433.
36. Lasne D, Fiemeyer A, Chatellier G, et al. A study of platelet functions with a new analyzer using high shear stress (PFA 100) in patients undergoing coronary artery bypass graft. Thromb Haemost 2000;84:794-799.
37. Clemmons RM, Meyers KM. Acquisition and aggregation of canine blood platelets: Basic mechanisms of function and differences because of breed origin. Am J Vet Res 1984;45:137-144.
38. Feingold HM, Pivacek LE, Melaragno AJ, Valeri CR. Coagulation assays and platelet aggregation patterns in human, baboon and canine blood. Am J Vet Res 1986;47:2197-2199.
39. Wahba A, Sander S, Birnbaum DE. Are in-vitro platelet function tests useful in predicting blood loss following open heart surgery? Thorac Cardiovasc Surg 1998;46:228-231.
40. Francis J, Francis D, Larson L, et al. Can the Platelet Function Analyzer (PFA®)-100 test substitute for the template bleeding time in routine clinical practice? Platelets 1999;10:132-136.
41. Kerenyi A, Schlammadinger A, Ajzner E, et al. Comparison of PFA-100 closure time and template bleeding time of patients with inherited disorders causing defective platelet function. Thromb Res 1999;96:487-492.
42. Jilma B. Platelet function analyzer (PFA-100): A tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med 2001; 138:152-163.
43. Chandrasekar B, Tanguay JF. Platelets and restenosis. J Am Coll Cardiol 2000;35:555-562.
44. Anderson HV, McNatt J, Clubb FJ, et al. Platelet inhibition reduces cyclic flow variations and neointimal proliferation in normal and hypercholesterolemic-atherosclerotic canine coronary arteries. Circulation 2001;104:2331-2337.
45. Nomura E, Kohriyama T, Yamaguchi S, et al. Association between carotid atherosclerosis and hemostatic markers in patients with cerebral small artery disease. Blood Coagul Fibrinolysis 1998;9:55-62.
46. Walsh PN, Kansu TA, Corbett JJ, et al. Platelets, thromboembolism and mitral valve prolapse. Circulation 1981;63:552-559.
47. Zuppiroli A, Cecchi F, Ciaccheri M, et al. Platelet function and coagulation studies in patients with mitral valve prolapse. Clin Cardiol 1986;9:487-492.
48. Tse HF, Lau CP, Cheng G. Relation between mitral regurgitation and platelet activation. J Am Coll Cardiol 1997;30:1813-1818.
49. Lin SL, Fisher MJ, Tak T, et al. Platelet activation in patients with mitral valve prolapse. Can J Cardiol 1989;5:84-86.
50. Freed LA, Levy D, Levine RA, et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 1999;341:1-7.